Riskpilot← Back to searchSign inGet full accessZelmic AB
ABActiveOrg 5567737738Sankt Lars Väg 45 BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20087 employees
Revenue 2024
SEK 8,7M
-36% vs 2024
EBITDA margin
5.9%
-78% vs 2024
Equity ratio
49.7%
Financial strength
Net profit 2024
SEK 202K
-85% vs 2024
| Revenue | SEK 8,7M | -36% |
| EBITDA | SEK 513K | -78% |
| Net profit | SEK 202K | -85% |
| Total assets | SEK 5,4M | -13% |
| Equity | SEK 2,7M | +8% |
| Employees | 7 | — |
Legal name
Zelmic AB
Org number
5567737738
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19 december 2008
Share capital
SEK 100 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Meyer, Karin Judith i förening med en av Larhed, Agneta Maria Sjöberg, Bror Folke Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva kontraktsutveckling av läkemedel samt därmed förenlig verksamhet.
Address
Sankt Lars Väg 45 B
Phone
+4646161240
Email
ekonomi@zelmic.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 8 294 | 9 101 | 8 652 | 8 120 | 12 776 | 10 503 | 13 558 | 8 687 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 739 | 821 | 1 105 | 361 | 462 | 971 | 1 161 | −1 815 | 2 288 | 513 |
| Depreciation & amort. | −64 | −65 | −86 | −122 | −112 | −129 | −140 | −164 | −233 | −162 |
| EBIT | 675 | 756 | 1 019 | 239 | 350 | 842 | 1 021 | −1 979 | 2 055 | 351 |
| Net financials | — | −7 | 8 | 31 | −824 | −800 | −313 | −433 | −172 | −3 |
| Profit before tax | 716 | 745 | 761 | 512 | −13 | 267 | 780 | −1 046 | 1 495 | 263 |
| Tax | −166 | −168 | −178 | −118 | −91 | −146 | −201 | −0 | −158 | −61 |
| Net profit | 550 | 577 | 583 | 394 | −104 | 121 | 579 | −1 046 | 1 337 | 202 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5 886 | 7 545 | 7 607 | 6 618 | 5 524 | 5 655 | 8 402 | 4 392 | 6 246 | 5 422 |
| Equity | 987 | 1 564 | 2 148 | 2 196 | 2 093 | 2 214 | 2 793 | 1 156 | 2 493 | 2 695 |
| Long-term debt | 3 000 | 3 000 | 1 750 | 810 | 506 | 0 | 1 093 | 836 | 569 | 0 |
| Short-term debt | 946 | 2 025 | 2 488 | 2 633 | 1 995 | 2 333 | 3 334 | 2 400 | 2 754 | 2 205 |
| Total debt | 3 946 | 5 025 | 4 238 | 3 443 | 2 501 | 2 333 | 4 427 | 3 236 | 3 323 | 2 205 |
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
20162024
Equity ratio
49.7%
This company
38.2%
Market median
+30% vs market
20162024
Return on equity
7.5%
This company
18.4%
Market median
-59% vs market
20162024
Net profit margin
2.3%
This company
8.1%
Market median
-72% vs market
20162024
Asset turnover
1.60×
This company
1.12×
Market median
+43% vs market
20162024
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-05-01 – 2024-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MN Chief Auditor | Chief Auditor | 2023 | — | — |
LM Chief Auditor | Chief Auditor | 2020 | — | — |
SA Chief Auditor | Chief Auditor | 2024 | — | — |
DB Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Center for Translational Research Sweden AB | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Center for Translational Research Sweden AB
Zelmic AB Board members of Zelmic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikael Nilsson | Chief Auditor | 0 companies |
| Lisa Maria Albertsson | Chief Auditor | 0 companies |
| Stéphanie Anna Chantal Ljungberg | Chief Auditor | 0 companies |
| David Ben Ibrahim Sagna | Chief Executive Officer | 0 companies |
| Susanna Karin Liljedahl | Board of Directors | 0 companies |
| Bengt Erik Dahlström | Board of Directors | 0 companies |
| Karin Judith Meyer | Chairman | 0 companies |
| Agneta Maria Larhed | Board of Directors | 0 companies |
| Anette Susanne Nilsson | Board of Directors | 0 companies |
| Åke Richard Lindal | Chairman | 0 companies |
| Jan Gunnar Hellqvist | Chairman | 0 companies |
| Inga Agneta Christina Rundquist | Deputy Board Member | 0 companies |
| Bror Folke Sjöberg | Deputy Board Member | 0 companies |
| Anna Matilda Holmberg | Board of Directors | 0 companies |